Botanix Pharmaceuticals Limited (BXPHF) Financials

BXPHF Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 73.1 million 29.3 million
Dec. 31, 2025 65.8 million 29.8 million
June 30, 2025 84.9 million 31.4 million
Dec. 31, 2024 61.8 million 4.3 million

BXPHF Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -22.1 million ?
Dec. 31, 2025 -21.8 million ?
June 30, 2025 -31.7 million 6.5 million
Dec. 31, 2024 -19.0 million 6.6 million

BXPHF Net Income

No data available :(

BXPHF Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 25.3 million - 309678
Dec. 31, 2025 21.1 million 10.9 million 414517
June 30, 2025 42.7 million 14.5 million 800814
Dec. 31, 2024 30.1 million 363136 538328

BXPHF Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 ?
Dec. 31, 2025 1.3 billion
June 30, 2025 1.2 billion
Dec. 31, 2024 1.1 billion

BXPHF Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 1569 - 3.5 million -
Dec. 31, 2025 1515 - 3.2 million -
June 30, 2025 128829 3862 34.6 million 19.5 million
Dec. 31, 2024 56250 85797 18.7 million 5.5 million

BXPHF Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 12.4 million 33.6 million
Dec. 31, 2025 11.0 million 30.2 million
June 30, 2025 3.6 million 1.7 million
Dec. 31, 2024 234629 751016

BXPHF

Price: $0.01

52 week price:
0.01
0.12

Payout Ratio Range:
-711.54%
1040.91%

Earnings Per Share: -0.02 USD

Exchange: PNK

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 43.7 million

Links: